PropThink: Peregrine Shares Continue to Bleed, Sticking Around Could Hurt Worse

[ACN Newswire] – By David MoskowitzPeregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results for bavituximab reported last … more

View todays social media effects on HALO

View the latest stocks trending across Twitter. Click to view dashboard